Outcomes of peroral endoscopic myotomy in patients with spastic esophageal motility disorders that do not fulfill Chicago Classification criteria.


Journal

Revista espanola de enfermedades digestivas
ISSN: 1130-0108
Titre abrégé: Rev Esp Enferm Dig
Pays: Spain
ID NLM: 9007566

Informations de publication

Date de publication:
11 2022
Historique:
pubmed: 3 2 2022
medline: 22 11 2022
entrez: 2 2 2022
Statut: ppublish

Résumé

per-oral endoscopic myotomy (POEM) has become a mainstream treatment for achalasia and is a promising therapy in spastic disorders. this is a retrospective study of prospectively collected data (case series). We present the first results of the use of POEM in patients with atypical spastic esophageal motor disorders that do not satisfy current Chicago Classification criteria. Seven consecutive patients with troublesome and persistent symptoms (12-180 months) related to atypical spastic esophageal motor dysfunction were systematically assessed before and after POEM, the extent of which was tailored by manometric findings. In five of the patients, other endoscopic or surgical procedures had failed. high-resolution manometry (HRM) showed a spastic esophageal body contractile segment in varying positions and lengths along the esophageal body which did not meet Chicago Classification criteria. After POEM, dysphagia and/or chest pain had either resolved or was greatly reduced. HRM 3-6 months after myotomy showed that the regions of spastic contraction targeted by myotomy had been ablated. There were no major complications. The clinical responses were fully maintained up to the most recent assessments after POEM (range 7-44 months). in our seven patients, POEM was a highly effective treatment for patients with troublesome symptoms related to atypical spastic esophageal motility disorders.

Identifiants

pubmed: 35105151
doi: 10.17235/reed.2022.8455/2021
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-647

Auteurs

Fermín Estremera-Arévalo (F)

Aparato Digestivo, Hospital Universitario de Navarra (HUN); Navarrabiomed; UPNA; IdiSNA, España.

Gonzalo González (G)

Aparato Digestivo, Hospital Universitario de Navarra (HUN), España.

Irene Areste (I)

Aparato Digestivo, Hospital Universitario de Navarra (HUN), España.

Sheyla Montori (S)

Gastrointestinal Endoscopy Research Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), UPNA, IdiSNA, España.

Alba Zúñiga (A)

Aparato Digestivo, Hospital Universitario de Navarra (HUN), España.

Sonia Ezquer (S)

Aparato Digestivo, Hospital Universitario de Navarra (HUN), España.

Rosa Iglesias (R)

Aparato Digestivo, Hospital Universitario de Navarra (HUN), España.

Elena Macías (E)

Aparato Digestivo, Hospital Universitario de Navarra (HUN), España.

Javier Alcedo (J)

Aparato Digestivo, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria de Aragón (IIS Aragón), España.

Ana Belén Domínguez Carbajo (AB)

Aparato Digestivo, Complejo Asistencial Universitario De León, España.

Mouen Khashab (M)

Gastroenterology, Johns Hopkins Hospital, USA.

John Dent (J)

Faculty of Health and Medical Sciences, The University of Adelaide, Australia.

Eduardo Albéniz (E)

Aparato Digestivo, Hospital Universitario de Navarra (HUN), Navarrabiomed, UPNA, IdiSNA, España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH